Top news of the week: 18.02.2020.
#BioTech #AAASmtg #AAAS2020 #innovation #NBTintheNews #BiogenProud
Healthcare
RT @rickberke: Congratulations to the one and only @sxbegle, honored with @AAASKavli gold award in Seattle last night for her groundbreaking reporting on Alzheimer's.
Read her story on Robert Moir, to whom she dedicated her award:
https://t.co/DpVWF2hoxB
#AAASmtg #AAAS2020
OpenHow an outsider in Alzheimer’s research bucked the prevailing theory — and clawed for validation
Even as potential Alzheimer’s drugs failed, researchers with fresh approaches struggled to get funded and to get studies published in top journals.
Priscilla Chan charts an ambitious, unglamorous course to fight disease. Zuck's involved, too.
by the inimitable @RebeccaDRobbins.
https://t.co/oTrLW3AoJv
OpenPriscilla Chan charts an ambitious, unglamorous course to fight disease. (Her husband is involved, too.)
The pediatrician and philanthropist insists the goal the couple has set — to “cure, prevent, or manage all diseases” by the year 2100 — is a realistic one.
Australian biotech industry struggling to keep innovations out of foreign hands #BioTech #innovation via https://t.co/2sI0UxJbpn https://t.co/rwFirzihIJ
OpenAustralia's biotech innovations heading offshore, prompting calls for greater funding to bring them to market
Australia's medical research and development industry punches above its weight, but much of its intellectual property is being sold overseas.
@UMNews @TAMU @FDAanimalhealth @agripulse FDA defends CRISPR-edited animal rules likely to block most uses: Is the agency trying to avoid litigation from anti-GMO groups? #NBTintheNews https://t.co/5kNOxRIpFX
OpenFDA defends CRISPR-edited animal rules likely to block most uses: Is the agency trying to avoid litigation from anti-GMO groups?
"How can the presence of one identifiable variant justify the costs and delays of mandatory FDA oversight?"
Entrepreneurship Club students help transfer Princeton biotech research to business ventures #BioTech via https://t.co/2sI0UxJbpn https://t.co/1goxuTzJxq
OpenEntrepreneurship Club students help transfer Princeton biotech research to business ventures
Students in the Princeton Entrepreneurship Club have formed a team called Alimtas BioVentures, which performs due diligence and develops pitches for technology developed through Princeton ...
Chutes & Ladders—Aerie taps former Allergan exec as new VP https://t.co/TrF1i1EReF https://t.co/2ZdlA95Yj7
OpenChutes & Ladders—Aerie taps former Allergan exec as new VP
Aerie nabs former Allergan exec Senchnya as VP of medical affairs; Novartis' Basson takes CMO role at Boston; Hannah tapped as CMO at CytomX.
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes #BioTech via https://t.co/2sI0UxJbpn https://t.co/N0uSDAUlSh
OpenBiotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
Congratulations to Dr. Cherie Butts, medical director and Head, Human Biology Research—Digital & Quantitative Medicine, for being named on @biospace's 10 Prominent African American Life Science Leaders list. #BiogenProud https://t.co/lXteZaJ0Xf
OpenCelebrating Black History Month: 10 Prominent African American Life Science Leaders
In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and ...